Cdx2 Controls Expression of the Protocadherin Mucdhl, an Inhibitor of Growth and β-Catenin Activity in Colon Cancer Cells

被引:43
作者
Hinkel, Isabelle [1 ,2 ]
Duluc, Isabelle [1 ,2 ]
Martin, Elisabeth [1 ,2 ]
Guenot, Dominique [2 ,3 ]
Freund, Jean-Noel [1 ,2 ]
Gross, Isabelle [1 ,2 ]
机构
[1] INSERM, U682, F-67200 Strasbourg, France
[2] Univ Strasbourg, Fac Med, F-67081 Strasbourg, France
[3] EA4438, F-67085 Strasbourg, France
关键词
Tumor Suppressor; cdhr5; Colorectal Cancer; CRC; HOMEOBOX GENE; COLORECTAL-CANCER; MU-PROTOCADHERIN; STEM-CELLS; INTESTINE; MOUSE; CADHERIN; PROTEINS; PROLIFERATION; TRANSCRIPTION;
D O I
10.1053/j.gastro.2011.12.037
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: The intestine-specific homeobox transcription factor Cdx2 is an important determinant of intestinal identity in the embryonic endoderm and regulates the balance between proliferation and differentiation in the adult intestinal epithelium. Human colon tumors often lose Cdx2 expression, and heterozygous inactivation of Cdx2 in mice increases colon tumorigenesis. We sought to identify Cdx2 target genes to determine how it contributes to intestinal homeostasis. METHODS: We used expression profiling analysis to identify genes that are regulated by Cdx2 in colon cancer cells lines. Regulation and function of a potential target gene were further investigated using various cell assays. RESULTS: In colon cancer cell lines, Cdx2 directly regulated the transcription of the gene that encodes the protocadherin Mucdhl. Mucdhl localized to the apex of differentiated cells in the intestinal epithelium, and its expression was reduced in most human colon tumors. Overexpression of Mucdhl inhibited low-density proliferation of colon cancer cells and reduced tumor formation in nude mice. One isoform of Mucdhl interacted with beta-catenin and inhibited its transcriptional activity. CONCLUSIONS: The transcription factor Cdx2 activates expression of the protocadherin Mucdhl, which interacts with beta-catenin and regulates activities of intestinal cells. Loss of Cdx2 expression in colon cancer cells might reduce expression of Mucdhl and thereby lead to tumor formation.
引用
收藏
页码:875 / U335
页数:14
相关论文
共 50 条
  • [21] Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer
    Xu, Weimin
    Zhu, Yilian
    Shen, Wei
    Ding, Wenjun
    Wu, Tingyu
    Guo, Yuegui
    Chen, Xiaobing
    Zhou, Mingxia
    Chen, Yingwei
    Cui, Long
    Du, Peng
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (05) : 1829 - 1842
  • [22] Pattern of Expression of CDX2 in Colorectal Cancer and its Role in Prognosis: An Ambispective Observational Study
    Singh, Jagdeep
    Rajesh, N. G. G.
    Dubashi, Biswajit
    Maroju, Nanda K. K.
    Ganesan, Prasanth
    Matta, Kiran K. K.
    Charles, I
    Kayal, Smita
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2022,
  • [23] CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors
    Priya, Swati
    Kaur, Ekjot
    Kulshrestha, Swati
    Pandit, Awadhesh
    Gross, Isabelle
    Kumar, Nitin
    Agarwal, Himanshi
    Khan, Aamir
    Shyam, Radhey
    Bhagat, Prakash
    Prabhu, Jyothi S.
    Nagarajan, Perumal
    Deo, S. V. S.
    Bajaj, Avinash
    Freund, Jean-Noel
    Mukhopadhyay, Arnab
    Sengupta, Sagar
    JOURNAL OF CELL SCIENCE, 2021, 134 (15)
  • [24] Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
    Jeong Mo Bae
    Tae Hun Lee
    Nam-Yun Cho
    Tae-You Kim
    Gyeong Hoon Kang
    World Journal of Gastroenterology, 2015, (05) : 1457 - 1467
  • [25] Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival an immunohistochemical study
    Melincovici, Carmen Stanca
    Bosca, Adina Bianca
    Susman, Sergiu
    Cutas, Ancuta
    Marginean, Mariana
    Ilea, Aranka
    Moldovan, Ioana Maria
    Jianu, Elena Mihaela
    Neag, Maria Adriana
    Bulboaca, Adriana-Elena
    Mihu, Carmen Mihaela
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2020, 61 (03) : 715 - 727
  • [26] Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
    Bae, Jeong Mo
    Lee, Tae Hun
    Cho, Nam-Yun
    Kim, Tae-You
    Kang, Gyeong Hoon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (05) : 1457 - 1467
  • [27] The clinical perspectives of CDX2 expression in colorectal cancer: A qualitative systematic review
    Olsen, J.
    Espersen, M. L. M.
    Jess, P.
    Kirkeby, L. T.
    Troelsen, J. T.
    SURGICAL ONCOLOGY-OXFORD, 2014, 23 (03): : 167 - 176
  • [28] Homeodomain protein CDX2 regulates COX-2 expression in colorectal cancer
    Kim, SP
    Park, JW
    Lee, SH
    Lim, JH
    Jang, BC
    Lee, SH
    Jang, IH
    Freund, JN
    Suh, SI
    Mun, KC
    Song, DK
    Ha, EM
    Lee, WJ
    Kwon, TK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (01) : 93 - 99
  • [29] LIN28B induces a differentiation program through CDX2 in colon cancer
    Suzuki, Kensuke
    Masuike, Yasunori
    Mizuno, Rei
    Sachdeva, Uma M.
    Chatterji, Priya
    Andres, Sarah F.
    Sun, Wenping
    Klein-Szanto, Andres J.
    Besharati, Sepideh
    Remotti, Helen E.
    Verzi, Michael P.
    Rustgi, Anil K.
    JCI INSIGHT, 2021, 6 (09)
  • [30] Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II-III colon cancer
    Hestetun, Kjersti Elvestad
    Aasebo, Kristine
    Rosenlund, Nina Benedikte
    Mueller, Yvonne
    Dahl, Olav
    Myklebust, Mette Pernille
    MODERN PATHOLOGY, 2021, 34 (01) : 161 - 170